SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 223 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $353,725 | -9.4% | 12,830 | -1.3% | 0.00% | -50.0% |
| Q2 2023 | $390,602 | -27.9% | 12,994 | -13.0% | 0.00% | +100.0% |
| Q1 2023 | $541,385 | -4.4% | 14,943 | -5.9% | 0.00% | 0.0% |
| Q4 2022 | $566,333 | -4.5% | 15,877 | -9.4% | 0.00% | -50.0% |
| Q3 2022 | $593,000 | +8.8% | 17,520 | -7.0% | 0.00% | +100.0% |
| Q2 2022 | $545,000 | -12.4% | 18,829 | -2.1% | 0.00% | 0.0% |
| Q1 2022 | $622,000 | -5.6% | 19,239 | -14.9% | 0.00% | 0.0% |
| Q4 2021 | $659,000 | +15.8% | 22,595 | +5.9% | 0.00% | 0.0% |
| Q3 2021 | $569,000 | -12.2% | 21,333 | +1.3% | 0.00% | -50.0% |
| Q2 2021 | $648,000 | +17.8% | 21,049 | +0.2% | 0.00% | 0.0% |
| Q1 2021 | $550,000 | +16.5% | 21,007 | +12.0% | 0.00% | 0.0% |
| Q4 2020 | $472,000 | -0.6% | 18,759 | -17.7% | 0.00% | 0.0% |
| Q3 2020 | $475,000 | -8.3% | 22,794 | +4.4% | 0.00% | 0.0% |
| Q2 2020 | $518,000 | +61.4% | 21,830 | +22.4% | 0.00% | 0.0% |
| Q1 2020 | $321,000 | -5.3% | 17,833 | +24.9% | 0.00% | 0.0% |
| Q4 2019 | $339,000 | -18.1% | 14,273 | -5.3% | 0.00% | 0.0% |
| Q3 2019 | $414,000 | +26.2% | 15,076 | +52.3% | 0.00% | 0.0% |
| Q2 2019 | $328,000 | -8.1% | 9,898 | -2.8% | 0.00% | 0.0% |
| Q1 2019 | $357,000 | +5.3% | 10,179 | -0.4% | 0.00% | 0.0% |
| Q4 2018 | $339,000 | -37.1% | 10,215 | -4.6% | 0.00% | -33.3% |
| Q3 2018 | $539,000 | -28.4% | 10,704 | -14.9% | 0.00% | -25.0% |
| Q2 2018 | $753,000 | +44.3% | 12,572 | +10.3% | 0.00% | 0.0% |
| Q1 2018 | $522,000 | +22.0% | 11,393 | +6.0% | 0.00% | +33.3% |
| Q4 2017 | $428,000 | -2.1% | 10,744 | -1.7% | 0.00% | 0.0% |
| Q3 2017 | $437,000 | +4.3% | 10,933 | +12.4% | 0.00% | 0.0% |
| Q2 2017 | $419,000 | +52.9% | 9,725 | +11.0% | 0.00% | +50.0% |
| Q1 2017 | $274,000 | +69.1% | 8,760 | -27.5% | 0.00% | 0.0% |
| Q4 2015 | $162,000 | – | 12,080 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |